Neurological diseases Flashcards

1
Q

Alzheimer’s disease

A

• Alzheimer’s disease is a major cause of dementia in the elderly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

__________ are accumulations of insoluble aggregates of amyloid beta peptide

A

Plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Alzheimer’s disease is characterized by ______________ and ____________

A

Plaques and tangles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

APP processing and the formation of AB peptide

A

• Amyloid precursor protein (APP) processing and formation of AB peptide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

As the diseases get more and more severe the plaques and tangles become ________

A

Worse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Alzheimer’s disease and synpases

A

Two majors themes that are important

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Impaired spatial learning and memory in a transgenic mouse model of Alzheimer’s disease

A

• in the morris water maze the wt mouse is able to find the platform faster with repeated trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

_____________ is important in learning and memory

A

Presenilin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Exogenous Amyloid Beta reduces dendritic spines and LTP in hippocampal sites

A

• Looking at the effect of applying amyloid (AB) peptides on neurons and its effects on dendrites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In the presence of AB peptide there is a reduction in ____________________ _______________ on dendrites

A

Dendritic spines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

____________ impairs LTP

A

Amyloid beta peptide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

_______________ not required for LTP

A

Caspase 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Appplying the AB peptide reduced the number of dendritic spines and impaired LTP so it is likely AB peptide is acting through _____________ to ____________LTP

A

Caspase 3 to Impair LTP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Presenilins

A

• The presenilin genes harbors mutations linked to early-onset familial Alzheimer’s disease (FAD), but how these mutations cause the disease is still being debated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Presnilins regulate synaptic function

A

Presenilins conditionally knocked out in mice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

___________ is involved in a number of effects in pre and post synaptic

A

Presenilin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

when presenilin is removed there is _________________ in Ca induced Ca release which can affect NT release, pair pulse facilitation and facilitation

A

Reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Postsynaptic presenilin can effect ho much ______ receptors are expressed on the post synaptic terminal which can have an effect on ________

A

NMDA, LTP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How does presenilin regulte Ca induced Ca release

A

How does presilin regulate Ca induced Ca release

20
Q

Pathogenic hypothesis for synaptic and neuronal toxicity in alzheirmenrs diseases

A

• AB amyloid hypothesis

21
Q

Fragile X syndrome

A

• Fragile X syndrome (FXS), a heritable intellectual and autism spectrum disorder (ASD), results from the loss of

22
Q

Fragile X syndrome gets worse as you ___

A

age

23
Q

Fragile X mental retardation proteins

A

• In a normal condition the releases of CGGs; in a normal individual there are about 5-55 of CGG repeats

24
Q

fragile X: the mGluR theory

A

• Stimulation of mGluR5 by glutamate induces local mRNA translation at the synapse.

25
Q

GABAergic signalling is rescued in FMR1 knockout mice; this could be due to…..

A

Effects on GABA receptors as well as various enzymes that make and break down GABA as well as various transporters that take up GABA

26
Q

Altered synapse formation and dendritic spine morphology in FXS

A

Can also have these effects on synapse formation and dendritic spine morphology

27
Q

Huntington’s disease

A

• HD is caused by a CAG repeat expansion in the gene encoding the protein huntingtin (Htt); 35 polyglutamine repeats or more lead to HD, with longer repeats being associated with earlier disease onset.

28
Q

Huntingtons______________over time

A

Progresses

29
Q

In huntingtons disease you have _______________________ impairment that gets progressively worse

A

Motor/cognitve

30
Q

Motor diagnosis is more apparent when the person is _____ of age

A

45 years

31
Q

Huntingtons structures and transformations

A

gene structures of the HTT gene

32
Q

Pathogenic cellular mechanisms in Huntingtons diseases

A

One cellular level

33
Q

HTT fragments form due to _________ ______________

A

CAG repeats

34
Q

HTT fragments has effects leading to _____________________________,________________________________ and ________________________

A

synaptic dysfunction, mitochondrial toxicity, and axonal transport impairments

35
Q

Huntingtons disease overview

A

• Control: we have a glutamatergic neuron releasing glutamte, glutamate binds to AMPA and NMDA receptors leading to phosphorylation of CREB and it has effects on transcription and translation on various genes important in synapses.

36
Q

Parkinson’s Disease

A

• Parkinson Disease (PD) is a neurodegenerative disorder affecting between 2-3 % of the population aged 65 or older.

37
Q

Parkinson’s disease gets worse as the individual _________

A

Ages

38
Q

Parkinson’s disease—Inherited mutations

A

• a-Synuclein

39
Q

a-Synulclein

A

Genetic studies of Parkinson’s Disease began with the discovery of pathogenic missense mutations in the gene SNCA that encodes α-synuclein, a protein that is expressed throughout the brain and has potential roles in learning, synaptic plasticity, vesicle dynamics and dopamine synthesis.

40
Q

Leucine-rich repeat kinase 2 (LRRK2)

A

• Leucine-rich repeat kinase 2 (LRRK2) has recently been implicated in Parkinson’s Disease and is thought to be involved in synaptic vesicle cycling and synaptic plasticity.

41
Q

Parkin

A

• Mutations in the parkin gene (PARK2) have been linked to Parkinson’s Disease.

42
Q

PTEN-induced kinase 1 (PINK1)

A

• Mutations in PINK1 have differential effects on protein stability, localization and kinase activity

43
Q

DJ1

A

• DJ1 seems to have essential roles in dopaminergic neuronal transmission and reward that is mediated by the dopamine D2 receptor.

44
Q

Parkinson’s disease overview

A

• If we start with synculin we have a mutation in SNCA gene that encodes for synulcin

45
Q

Amyotrophic lateral sclerosis

A

• Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is primarily characterized by the degeneration of both upper and lower motor neurons, which leads to muscle weakness and eventual paralysis.

46
Q

Mutations in several genes implicated in ALS exert motor neuronal injury though multiple mechanisms

A

• A lot of things happening—leads to mitochondrial disfunction, oxidative stress, impaired protein homeostasis, effects on DNA and RNA